Similar to previously reported,21 we found that a high percentage of HD (pre‐COVID‐19 samples) presented detectable CD4+ and CD8+ SARS‐CoV‐2 specific T‐cell response (75% and 82%, respectively, Figure 2). This evidence concerns the gene CD4 and Huntington disease.